Albaconazole

Albaconazole (development code UR-9825) is an experimental triazole antifungal.[1] It has potential broad-spectrum activity and exhibits inhibition of numerous CYP450 hepatic enzymes.

Albaconazole
Clinical data
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.170.829
Chemical and physical data
FormulaC20H16ClF2N5O2
Molar mass431.823146 g/mol g·mol−1
3D model (JSmol)
  (verify)

It has also been studied as an antiprotozoal agent.[2]

References

  1. "Albaconazole". Adis Insight.
  2. Guedes, P. M. d. M.; Urbina, J. A.; De Lana, M.; Afonso, L. C. C.; Veloso, V. M.; Tafuri, W. L.; Machado-Coelho, G. L. L.; Chiari, E.; Bahia, M. T. (2004). "Activity of the New Triazole Derivative Albaconazole against Trypanosoma (Schizotrypanum) cruzi in Dog Hosts". Antimicrobial Agents and Chemotherapy. 48 (11): 4286–4292. doi:10.1128/AAC.48.11.4286-4292.2004. PMC 525424.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.